Financing for hepatitis

Financing for hepatitis

Financing should not be barrier to elimination

Without fully-funded national plans, countries will not have the resources to scale-up the services needed to find the missing millions. Nor will they have the ability to provide treatment and adequate preventative measures. WHA has a suite of resources and activities to support national activities.

MAKING THE INVESTMENT CASE

Eliminating hepatitis B and hepatitis C as public health threats by 2030 would prevent approximately 36 million infections and save 10 million lives globally. This alone would reduce global healthcare costs and advance the Sustainable Development Goals. Viral hepatitis can be eliminated by 2030 but only if it’s made a priority now. Download the “Making the Investment Case” advocacy two-pager here. The arguments set out in this advocacy tool are explored in greater detail here.

NATIONAL VIRAL HEPATITIS PROGRAMME FINANCING STRATEGY TEMPLATE

The National Viral Hepatitis Programme Financing Strategy Template is a guide for countries facing the challenge of fully funding their hepatitis response. It sets out a strategic approach to costing, creating the investment case, budgeting, and financing a viral hepatitis programme. It also explores advocating for financing and the important role that civil society have to play in this.

Access the National Viral Hepatitis Programme Financing Strategy Template here.